Thinly traded nano cap NeuroMetrix (NURO +6%) turns from red to green for the session after it announced that the USPTO has issued Patent No. 9,656,070 protecting its Quell device. The patent covers the novel application of real-time accelerometer measurements to control transcutaneous electrical nerve stimulation.
Quell is a neurostimulation device that is worn around the upper calf to provide pain relief due to diabetes, fibromyalgia, arthritis and in the lower back and leg.
Subscribe for full text news in your inbox